Synaptogenix, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 12.61 million compared to USD 12.7 million a year ago. Basic loss per share from continuing operations was USD 2.51 compared to USD 12.03 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.61 USD | +5.49% |
|
+10.55% | -32.18% |
05-15 | Synaptogenix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
-32.18% | 5.69M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- SNPX Stock
- News Synaptogenix, Inc.
- Synaptogenix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021